Oxygen Versus PAP for Sleep Apnea in Heart Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

June 23, 2014

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Heart FailureSleep Apnea Syndromes
Interventions
DEVICE

Continuous positive airway pressure

Nocturnal continuous positive airway pressure, titrated to minimize apnea-hypopnea index

DEVICE

Nocturnal supplemental oxygen

Nocturnal supplemental oxygen, titrated to 2-4 liters/minute with target of eliminating nocturnal hypoxemia

BEHAVIORAL

Healthy Lifestyle and Sleep Education

A 60-minute educational intervention with slide show and printed materials, educating the patient in healthy sleep habits and heart-healthy lifestyle

Trial Locations (2)

06516

VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven

02130

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT01807897 - Oxygen Versus PAP for Sleep Apnea in Heart Failure | Biotech Hunter | Biotech Hunter